Stirling Anglian Pharmaceuticals

Stirling Anglian Pharmaceuticals is a UK-based pharmaceutical company dedicated to developing value-based solutions that support the delivery of efficient and cost-effective healthcare. The company collaborates closely with stakeholders across the NHS to identify real-world problems and create tailored solutions. Stirling Anglian Pharmaceuticals places a high emphasis on patient safety, with a robust pharmacovigilance infrastructure to ensure compliance with reporting requirements and adaptability to future needs and trends. The pharmacovigilance team, based at Jenson R offices, manages safety issues for both marketed products and those in the product pipeline. Additionally, the team supports medical information, marketing activities, and customer liaison. The company's Regulatory Affairs department, located at Barnstaple offices, handles the licensing process for new products, variations to existing licenses, and the maintenance of Summary of Product Characteristics (SPC) publishing. Stirling Anglian Pharmaceuticals generates revenue through the development and sale of pharmaceutical products, serving healthcare providers and institutions within the NHS.

Keywords: value-based solutions, patient safety, pharmacovigilance, regulatory compliance, NHS collaboration, healthcare efficiency, cost-effective healthcare, medical information, product licensing, safety data exchange.